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Legal Issues Concerning Public Health Efforts To Reduce
Perinatal HI1V Transmission
Zita Lazzarini, J.D., M.P.H. * and Lorilyn Rosales, J.D.t'
Since its inception in 1981, the Human Immunodeficiency Virus /
Acquired Immune Deficiency Syndrome (HIV / AIDS) epidemic has
raised challenging legal and ethical questions for public health officials,
physicians, policymakers, patients, lawyers, and ethicists. Although HIV /
AIDS mostly affects adults in their prime working years, it has also emerged
as a pediatric health problem. Current estimates indicate that in the
absence of effective maternal treatment, eight hundred thousand children
worldwide born to HIV-infected mothers will be infected each year. Yet,
one of the most significant advances of the epidemic has been the
discovery that antiretroviral medications taken by the mother during
pregnancy and delivery, and by the child after birth, can greatly reduce the
risk of HIV transmission.' As a result, the United States and the rest of the
global community have the opportunity to take proactive steps toward the
reduction and virtual elimination of perinatal HIV transmission.
This Article explores the legal issues related to the reduction of
perinatal HIV transmission in the United States to demonstrate that
proper education, along with voluntary testing and treatment during
pregnancy, can significantly reduce such transmission. Part I examines the
history of this topic from a medical perspective, focusing on studies of
efforts to reduce perinatal transmission. Part II looks at the evolution of
recommendations, policies, and laws regarding the testing and treatment
* Zita Lazzarini is the Director of the Division of Medical Humanities, Health Law, and
Ethics at the University of Connecticut Health Center.
t Lorilyn Rosales is an associate at Pullman & Comley, L.L.C.
*+ The origin of this project is deeply indebted to the support of Professor Lawrence 0.
Gostin. The original survey of state laws and policies was supported by Professor Gostin and
a cooperative agreement with the Council of State and Territorial Epidemiologists (CSTE)
and the Centers for Disease Control (CDC). Extensive additional research and analysis has
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See infta Part I.
2 Perinatal HIV transmission is the transmission of HIV from mother to child during
pregnancy or during birth.
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of HIV-positive pregnant women. Part III examines existing state laws
regarding HIV testing and counseling, while Part IV reviews legal
challenges to these and related laws. With the current medical, legal, and
policy information in mind, Part V makes recommendations concerning
state legal interventions to reduce perinatal HIV transmission. Part VI
concludes that a carefully crafted policy of routine testing that
incorporates informed consent is the key to a viable strategy to reduce HIV
transmission.
I. THE MEDICAL PROBLEM OF PERINATAL HIV TRANSMISSION AND
TREATMENT
To comprehend the scope and challenge of the problem of perinatal
HIV transmission, it is important to place perinatal transmission in the
context of the HIV epidemic among women and men worldwide. In its
report on the global HIV / AIDS epidemic, the United Nations Joint
Programme on AIDS (UNAIDS) estimated that forty million men, women,
and children were living with HIV / AIDS at the end of 2001.3 In addition,
approximately 2.5 million women with HIV / AIDS become pregnant every
year. From such pregnancies, an estimated eight hundred thousand
infants were infected in 2001.
Since the vast majority of pediatric HIV infections are acquired
perinatally, the most effective means of preventing pediatric HIV infection
is to prevent infection of women in general.6 Even for women who are
already infected, intervention can substantially reduce HIV transmission
from mother to child.
Until the early 1990s, the only known methods to reduce perinatal
HIV transmission were to counsel women to avoid pregnancy and to
discourage HIV-positive mothers from breastfeeding.7 In 1994, however, a
study by the Pediatric AIDS Clinical Trial Group 076 (PACTG 076)
revealed that maternal and neonatal zidovudine (ZDV) treatment reduced
perinatal HIV transmission by sixty-six percent.8 While twenty-five percent
'JOINT UNITED NATIONS PROGRAMME ON AIDS, REPORT ON THE GLOBAL H1V / AIDS EPIDEMIC
8 (2002), available at http://www.unaids.org/epidemic-update/report july02/.
'Id. at 128.
Robert Steinbrook, Preventing HIVInfection in Children, 346 NEw ENG. J. MED. 1842, 1842
(2002).
6 Kevin M. De Cock et al., Prevention of Mother-to-Child HIV Transmission in Resource-Poor
Countries: Translating Research into Policy and Practice, 283 JAMA 1175, 1178 (2000).
' Lynne M. Mofenson & James A. McIntyre, Advances and Research Directions in the Prevention
of Mother-to-Child HIV-1 Transmission, 355 LANCET 2237, 2237 (2000).
' Edward M. Connor et al., Reduction of Maternal-Infant Transmission of Human
Immunodeficiency Virus Type 1 with Zidovudine Treatment, 331 NEw ENG. J. MED. 1173, 1173
111: 1 (2002)
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of infants of mothers taking placebo were infected, the figure dropped to
about eight percent with ZDV-treated mothers!
Subsequent innovations in the treatment of pregnant women and
newborns further reduced rates of perinatal HIV transmission. For
instance, highly active combination antiretroviral therapies for the mother,
or the combination of maternal ZDV treatment and a caesarean delivery,
reduce transmission to less than two percent.0 In fact, since adopting
combination therapy for pregnant women in 1994 both the United States
and Western Europe have witnessed a sharp decline in perinatal HIV
transmission." Specifically, in the United States, the number of reported
cases of perinatal HIV transmission has decreased every year since 1992,
from 901 new cases in 1992, to approximately 144 newly infected infants in
1999.12 Thus, treating HIV-infected pregnant women with certain
antiretroviral drugs in a timely fashion can significantly reduce rates of
perinatal HIV transmission.
II. POLICY DEVELOPMENTS REGARDING THE REDUCTION OF PERINATAL HIV
TRANSMISSION
Since the success of the PACTG 076 protocol and other interventions
in preventing perinatal transmission, American public health officials and
clinicians have recognized the importance of determining the HIV status
of pregnant women for early and timely treatment. Accordingly, the
policies of government-sponsored agencies and professional organizations
regarding perinatal HIV transmission have altered, changing both the way
pregnant women are targeted for counseling and HIV testing, and the way
(1994).
9 Id.
10 Lynne M. Mofenson, Perinatal Exposure to Zidovudine B-Benefits and Risks, 343 NEW ENG. J.
MED. 803, 803 (2000).
" Unfortunately, the rapid decline in perinatal HIV cases in the United States and other
developed countries was not matched worldwide. Approximately ninety-five percent of
people with HIV / AIDS live in developing countries. U.S. AGENCY FOR INT'L DEV., GLOBAL
HEALTH, HLV / AIDS: FREQUENTLY ASKED QUESTIONS, at
http://www.usaid.gov/pophealth/aids/News/aidsfaq.html (last visited Dec. 8, 2002).
According to UNAIDS, at the end of 2001, there were three million children living with
HIV. JOINT UNITED NATIONS PROGRAMME ON AIDS, supra note 3, at 8. In 2001, the United
Nations Children's Fund (UNICEF) reported that of eight hundred thousand children with
HIV, most (ninety percent) were infected during birth or through breastfeeding. UNITED
NATIONS CHILDREN'S FUND, MOTHER-TO-CHILD TRANSMISSION OF HIV 2 (2002), available at
http://unicef.org/pubsgen/hiv-mothertochild/fact-sheet-mtct-en.pdf. For most HIV-
infected women in the world, therapy to reduce the risk of perinatal transmission remains
unavailable.
"2 Centers for Disease Control and Prevention, HIV and AIDS-United States, 1981-2000, 50
MORBIDITY& MORTALITY WKLY. REP. 430, 433 (2001).
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HIV tests are explained and administered. While these reforms have made
perinatal testing more broadly inclusive, they have also tended to de-
emphasize the role of pretest counseling and informed consent.
A. Policy Development by Governmental Agencies, Congress, and the IOM
Although HIV / AIDS appeared on the global scene in the early 1980s,
the U.S. moved relatively slowly in developing a policy response. In 1985,
the Centers for Disease Control and Prevention (CDC) issued guidelines
for HIV counseling and testing that focused on high-risk women, e.g.,
intravenous drug users and women whose sexual partners were HIV-
infected or at risk for infection. 13 Specifically, the CDC recommended
testing for women who were pregnant or who might become pregnant if
they (1) had evidence of HTLV-III / LAV 1 4 infection; (2) used drugs
intravenously for non-medical purposes; (3) were born in countries where
heterosexual transmission is thought to play a major role; (4) engaged in
prostitution; or (5) had been sex partners of intravenous drug abusers,
bisexual men, men with hemophilia, men born in countries where
heterosexual transmission is thought to play a major role, or men who
otherwise had evidence of HTLV-III / LAV infection. 15 The CDC
recommended that an infected women be "advised to consider delaying
pregnancy . . . [and] be advised against breast-feeding to avoid postnatal
transmission to a child who may not yet be infected."1 6 However, the CDC
did not advocate routine counseling and testing for women not in the
aforementioned groups "due to the low prevalence of infection and
concern about interpretation of test results in a low-prevalence
population." 7
In 1988, the Presidential Commission on the Human
Immunodeficiency Virus Epidemic issued a report calling for a national
plan to help fight the spread of HIV and AIDS.'8 Although the report made
a number of broad suggestions to promote research and help protect the
" Centers for Disease Control and Prevention, Recommendations for Assisting in the Prevention
of the Perinatal Transmission of Human T-Lymphotropic Virus Type III / Lymphadenopathy-
Associated Virus and Acquired Immunodeficiency Syndrome, 34 MORBIDITY & MORTALITY WKLY.
REP. 721, 724-26 (1985) [hereinafter CDC Recommendations].
"4 HTLV-III / LAV, which was the early designation for HIV, stands for human T-
lymphotropic virus type III / lymphadenopathy-associated virus.
"CDC Recommendations, supra note 13, at 724.
Id. at 725.
17Id.
1 REPORT OF THE PRESIDENTIAL COMMISSION ON THE HUMAN IMMUNODEFICIENCY VIRUS
EPIDEMIC (1988). President Reagan appointed the commission in May 1987.
111: 1 (2002)
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public, it did not address the specific issue of perinatal HIV transmission.' 9
The ensuing Ryan White Comprehensive AIDS Resources Emergency
(CARE) Act of 1990 allocated funding to help states, cities, and hospitals
with a disproportionate number of AIDS cases provide treatment and
support services for persons with HIV and AIDS.20 Like the commission
report, however, this legislation did not explicitly mention perinatal HIV
transmission.
In response to the 1994 PACTG 076 results, the CDC recommended
counseling on the risks of HIV and voluntary testing for all pregnant
women, as well as counseling on treatment and prevention of perinatal
transmission for infected women.2 ' The CDC's official 1995 guidelines
specifically added that pregnant, HIV-infected women should be offered
antiretroviral treatment and that all HIV-exposed newborns should be
monitored for early diagnosis and treatment. 2 In these guidelines, the
CDC emphasized the benefits of routine, voluntary testing as opposed to
mandatory testing, which might deter women from seeking prenatal care.
23
In support of its position, the CDC relied on data from routine HIV
counseling and testing programs showing that high levels of testing could
24
be achieved without mandatory testing.
In 1996, Congress reauthorized the Ryan White CARE Act, amending
and approving the specific spending priorities and programs originally
contained in the legislation. During the reauthorization hearings,
Congress struggled with various means to reduce perinatal HIV
transmission. The final amendments required all states to adopt the CDC
guidelines on HIV counseling and voluntary testing for pregnant women.25
"9 See id. The Commission's suggestions included local and state government promotion of
HIV testing and counseling and the enactment of HIV-specific criminal statutes penalizing
conduct that created a risk of transmitting HIV. As a result of these recommendations, all
fifty states adopted various forms of HIV / AIDS legislation to promote HIV awareness, case
reporting, and testing. See Stephen V. Kenney, Comment, Criminalizing HIV Transmission:
Lessons from History and a Model for the Future, 8 J. CONTEMP. HEALTH L. & POL'Y 245, 260
(1992).
2' 42 U.S.C. §§ 300ff et seq. (1990).
21 See Centers for Disease Control and Prevention, U.S. Public Health Service Recommendations
for Human Immunodeficiency Virus Counseling and Voluntary Testing for Pregnant Women, 44(RR-
7) MORBIDITY & MORTALITY WKLY. REP. 1, 8, 10 (1995) [hereinafter CDC 1995
Recommendations].
22 Id. at 10-11.
23Id. at 6.
24 Id. While the CDC's support of voluntary rather than mandatory testing is well founded, it
is crucial for all pregnant women to be properly counseled about the benefits of being
tested as well as their options, including their right to refuse testing.
25 42 U.S.C. § 300ff-33(a) (1996). To demonstrate compliance, states had to show a fifty
percent reduction in AIDS cases stemming from HIV transmission, a ninety-five percent
5
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In particular, under the final amendments, if a state failed to adopt the
CDC guidelines, it risked losing the funding it received under the Ryan
White CARE Act of 1990.26 The amendments also required that each state
annually assess its incidence of perinatal HIV transmission and evaluate
potential reasons for failure to prevent perinatal transmission.27 Compliant
states could avail themselves of the $10 million set aside for HIV
counseling, testing of pregnant women, prenatal care for women with a
high risk of infection, and implementation of the CDC guidelines. 8 In
addition, compliant states with the highest rates of HIV infection among
pregnant women received priority for these funds. 9
Moreover, in the 1996 amendments to the Ryan White CARE Act,
Congress requested that the National Academy of Sciences evaluate state
efforts to reduce perinatal HIV transmission. The Institute of Medicine
(IOM) initiated the requisite study in 1997 and issued its report in 1999.
The report concluded that despite reductions in perinatal H1V
transmission, the number of babies born with HIV was higher than
attainable levels of prevention. ° Specifically, prenatal HIV testing had not
become universal practice, and consequently many infected women did
not receive adequate treatment. Furthermore, the report noted that some
health care providers did not offer tests to patients whom they believed
were "low risk," and other providers neglected to do so because they found
the pretest counseling requirements burdensome." The IOM concluded
that, in light of the advances in antiretroviral therapy and its significant
potential to reduce perinatal H1V transmission, "the United States should
adopt a national policy of universal HIV testing, with patient notification, as
a routine component of prenatal care."32 As the executive summary of the
IOM report explains:
There are two key elements to the committee's recommendation. The
first is that HIV screening should be routine with notification. This means
that the test for HIV would be integrated into the standard battery of
prenatal tests and women would be informed that the HIV test is being
HIV testing rate of women with two prenatal visits or more prior to thirty-four weeks
gestation, or state legislation or regulations requiring the testing of all newborns whose
mothers have not been tested for HIV. Id. § 300ff-34(e) (2).
26 Id. § 300ff-33(b).
27 Id. § 300ff-34(a)-(b).
281 Id. § 300ff-33(c).
2Id.
'0 INST. OF MED., REDUCING THE ODDS: PREVENTING PERINATAL TRANSMISSION OF HIV IN THE
UNITED STATES 5-6 (Michael A. Stoto et al. eds., 1999).
See id. at 107.
32 Id. at 6 (emphasis added).
111:l1(2002)
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conducted and of their right to refuse it .... The second key element to
the recommendation is that screening should be universal meaning that
it applies to all pregnant women, regardless of their risk factors and of
prevalence rates where they live.3
In 2000, Congress again reauthorized the Ryan White CARE Act,
providing $30 million to support grants for partner counseling and referral
services for individuals who tested positive for HIV. 34 The 2000
amendments also asked the Secretary of Health and Human Services to
contract with the IOM to study the status of perinatal HJV transmission.35
Furthermore, provisions pertaining to perinatal transmission were altered
to authorize an additional $30 million in grants for the counseling, testing,
36and treatment of pregnant women. While existing programs received the
first $10 million, a percentage of the remaining funds was reserved for
states that could demonstrate a substantial decrease in perinatal
transmission and for states that required newborn testing. Thus, states that
were most aggressive in their efforts to prevent perinatal HIV transmission
received the most funding.
In 2001, the CDC issued long-awaited revisions of its recommendations
for HIV counseling and testing of pregnant women.3 7 The revised
guidelines differed from the 1995 guidelines insofar as they emphasized
HIV testing as a routine part of prenatal care. To achieve the goal of
testing all pregnant women for HIV, the CDC recommended that the test
process be simplified so that pretest counseling would no longer be a
barrier; that various types of informed consent be allowed; that health care
providers explore and address a woman's reasons for refusing testing; and
that HIV testing and treatment be offered to women who had not received
prenatal testing and antiretroviral drugs.8 Furthermore, in November of
2002, the CDC issued comprehensive recommendations for the use of
antiretroviral drugs during pregnancy that reiterated the importance of
13 Id. (emphasis original).
Ryan White Comprehensive AIDS Resources Emergency (CARE) Act Amendments of
2000, Pub. L. No. 106-345, § 2631, 114 Stat. 1319.
35 Id. § 213. The Secretary of Health and Human Services, with the aid of the 1OM, was to
examine the following: (1) the number of newborns born with HIV where the attending
obstetrician was unaware of the mother's HIV status; and (2) barriers existing in states that
prevent an obstetrician from routinely testing pregnant women or testing newborns when
the HIV status of the mother is unknown. The Secretary was to recommend ways to remove
such barriers and reduce transmission. Id.
36 Id. § 212.
31 Centers for Disease Control and Prevention, Revised Guidelines for HIV Counseling, Testing,
and Referral and Revised Recommendations for HIV Screening of Pregnant Women, 50(RR-19)
MORBIDITY& MORTALITY WKLY. REP. 59 (2001) [hereinafter CDC revised guidelines].
" Id. at 59.
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early testing and treatment of pregnant women to prevent HIV
transmission to their fetuses.9
In sum, at least two important themes emerged from the CDC's 2001
revisions and 2002 recommendations. First, the CDC endorsed making
HIV testing a routine part of prenatal care (i.e., one that all physicians and
midwives should pursue with all pregnant patients). Second, the CDC
recommended the simplification of the informed consent requirements
for HIV testing. Although the CDC continues to recommend that HIV
testing of pregnant women be voluntary, these revisions demonstrate a
shift in the CDC's position toward more routine HlV testing of pregnant
women.
B. Perinatal HIV Transmission Policies of Professional Organizations
The shift in emphasis toward more routine testing of pregnant women
for HIV appears not only in federal legislation and CDC guidelines, but
also in the policies of professional organizations closely involved in
prenatal care. While some organization policies have closely mirrored
those of the IOM, others have retained more emphasis on informed
consent and voluntary testing than either the CDC (in its 2001
recommendations) or the IOM. Although not binding on their members
or on public or private policy, position statements and recommendations
from professional organizations attest to a developing standard of care
among providers of prenatal and newborn care. These recommendations
also indicate the level of professional support for official policies and laws
adopted by legislatures and health agencies. Indeed, these positions can
influence the development of the CDC's recommendations, and Congress
often uses adoption of CDC recommendations as a criterion for receiving
certain categories of federal funding. 40 Therefore, the policies of
professional organizations can potentially impact cash-strapped states and
health agencies.
Among professional organizations, the American College of
Obstetricians and Gynecologists (ACOG) took one of the more aggressive
positions by launching a campaign for universal HIV screening of all
pregnant women. 4' The ACOG is motivated by scientific advances made in
" See Centers for Disease Control and Prevention, U.S. Public Health Service Task Force
Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-l-Infected Women for Maternal
Health and Interventions To Reduce Perinatal HIV-1 Transmission in the United States, 51 (RR-18)
MORBIDITY& MORTALITY WKLY. REP. 1 (2002).
40 See, for example, the 1996 Amendments to the Ryan White CARE Act, described supra in
Part 11A.
4' Press Release, American College of Obstetricians and Gynecologists, HIV Tests Urged for
111: 1 (2002)
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the "prevention of perinatal transmission of HIV, testing for HIV, and the
treatment of HIV-infected women., 42 The ACOG recommends that all
pregnant women in the U.S. be tested for HIV as a routine part of prenatal
care.43 Although the ACOG does not advocate mandatory testing, its goal is
to implement universal testing with notification and the right to refuse.44
Other professional organizations also endorse routine HIV counseling
and testing for pregnant women, but insist that testing be of the opt-in
variety rather than of the opt-out variety advocated by the ACOG and the
IOM. For example, while the American College of Nurse Midwives
(ACNM) recognizes the importance of preventing perinatal HIV
transmission, it opposes mandatory testing as a condition of prenatal care.45
Instead, the ACNM recommends that "all women should be counseled on
HIV risk behaviors and risk reduction strategies. Following counseling, all
women should be offered HIV testing with informed consent.
"4
Reiterating the importance of identifying HIV-positive pregnant women,
the American Academy of Pediatrics (AAP) recommends "documented,
routine HIV education, and routine testing with consent, for all pregnant
women in the United States" as well as "utilization of consent procedures
that facilitate rapid incorporation of HIV education and testing into the
routine medical care setting.
"
01
The American Public Health Association (APHA) also opposes
mandatory HIV testing of pregnant women. Its 1995 policy statement,
entitled "Opposition to Mandatory H1V Testing of Pregnant Women,"
explicitly urged the federal government to prohibit mandatory testing of
pregnant women.48 As an alternative, the APHA recommends that the
Department of Health and Human Services educate health care providers
on HIV counseling and voluntary testing for pregnant women, and that
health care providers "routinely recommend counseling and voluntary






4 American College of Nurse Midwives, Reducing Perinatal Transmission of HIV / AIDS: A
Tip Sheet for ACNM State Legislative Contacts (Nov. 1999) (on file with the Yale Journal of
Health Policy, Law, and Ethics).
46 Id.
47 American Academy of Pediatrics, Perinatal Human Immunodeficiency Virus Testing (RE9507),
95 PEDIATRICS 303, 306 (1995), available at http://www.aap.org/policy/re9507.html.
48 
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",49testing with informed consent to women, especially pregnant women.
Similarly, the American Medical Association (AMA) endorsed the CDC's
1995 recommendations with regard to HIV counseling and voluntary
testing for pregnant women.0 In 1998, the AMA issued a recommendation
for routine voluntary testing, stating that, "a system for offering HIV tests
in the intrapartum period, using a good faith effort to ensure an informed
process of consent, is reasonable." 5'
In short, the consensus among many professional organizations
involved in the delivery of care for pregnant women favors routine testing
with consent-as opposed to mandatory testing-to prevent perinatal HIV
transmission. In particular, while the ACOG recommends that women be
given the right to refuse testing, the ACNM, the AAP, the AMA, and the
APHA have been more protective of women's rights, recommending that
pregnant women be counseled and given an opportunity to consent prior
to testing. Thus, although the public health justification for HIV testing of
pregnant women is very strong, it appears most professionals would not
override a pregnant woman's right to participate in the testing decision.
III. EVALUATING EXISTING STATE LAWS ON HIV TESTING AND COUNSELING
Since 1981, every state has adopted HIM-specific laws. While thirty-
seven states have general HIV testing statutes, only seventeen have prenatal
testing statutes,52 and only four have newborn testing statutes. 53 To
understand the legal measures in place to reduce perinatal HIM
transmission, it is important to examine the structure of HIV testing and
counseling laws in each state.
A. General HV Testing Statutes
General HIV testing statutes establish each state's overall approach to
HIV testing, pretest counseling, and the role of informed consent in the
testing process. In states and territories with no specific statute covering
HIV testing of pregnant women, general HIV testing statutes govern how
pregnant women may be tested. Three types of informed consent policies
are found in many of these statutes: (1) voluntary testing with written
49 Id.
"' See CDC 1995 Recommendations, supra note 21.
5' Howard Minkoff & Mary Jo O'Sullivan, The Case for Rapid HIV Testing During Labor, 279
JAMA 1743, 1744 (1998).
52 Arkansas, California, Connecticut, Delaware, Florida, Indiana, Iowa, Maryland, Michigan,
New jersey, Pennsylvania, Rhode Island, Tennessee, Texas, Virginia, Washington, and West
Virginia have prenatal testing statutes.
" Connecticut, Indiana, New York, and Rhode Island have newborn testing statutes.
111:1 (2002)
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informed consent; (2) voluntary testing with informed consent (which may
be written or oral, or not specified in the statute); and (3) testing based on
general consent to medical testing and treatment.
1. Voluntary Testing with Written Informed Consent
Fifteen states have statutes classified as voluntary testing with written
informed consent.54 The statutes require documentation via a general
consent form for medical or surgical treatment that specifically includes
consent for HIV antibody or antigen testing,55 a form that contains specific
information about the risks and benefits of HIV testing and counseling,56
or a form that simply contains a written statement signed by the patient
indicating that she consents to HIV testing, without delineating the risks
and benefits of testing.57 Of the fifteen states that require voluntary testing
with written informed consent, twelve also require health care providers to
include pretest counseling as part of HIV testing.58 Among these twelve
states, nine specify what pretest counseling entails.59 Maine's statute is
typical:
"Pre-test counseling" must include [f]ace-to-face counseling that
includes, at a minimum, a discussion of: (1) the nature and reliability of
the test being proposed; (2) the person to whom the results of the test
may be disclosed; (3) the purpose for which the test results may be used;
(4) any reasonably foreseeable risks and benefits resulting from the test;
and (5) information on good HIV preventative practices and HIV risk
reduction plans; and [a] written memorandum summarizing the
5' Alabama, Arizona, California, Hawaii, Illinois, Maine, Maryland, Massachusetts, Michigan,
Nebraska, New York, North Dakota, Pennsylvania, Rhode Island, and Wisconsin have such
statutes.
" See, e.g., ALA. CODE § 22-1IA-51(b) (2002) ("A general consent form should be signed for
medical or surgical treatment which specifies the testing for HIV infection by any antibody
tests or other means and may be considered as meeting the standard of informed consent..
56 See, e.g., CONN. GEN. STAT. § 19a-582(b) (2002) (requiring that informed consent include
a statement that the health care provider explained to the patient a variety of matters
related to HIV testing).
-" See, e.g., CAL. HEALTH & SAFETY CODE § 120990(a) (Deering 2002) ("The person giving the
test shall have a written statement signed by the subject or conservator or other person..
confirming that he or she obtained the consent from the subject.").
58 Arizona, Hawaii, Illinois, Maine, Maryland, Massachusetts, Michigan, Nebraska, New York,
North Dakota, Pennsylvania, and Rhode Island have such requirements.
' Arizona, Illinois, Maine, Maryland, Michigan, Nebraska, New York, North Dakota, and
Pennsylvania have such provisions.
11
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contents of the discussion .... o
In contrast, three states, Hawaii, Massachusetts, and Rhode Island,
prescribe pretest counseling in more general terms, thereby leaving more
discretion to the health care provider. For example, Massachusetts defines
pretest counseling as simply "a face-to-face meeting . . . between the
member [of the community] and a physician, physician assistant, nurse
practitioner, registered nurse, or counselor . . for the purpose' of
providing counseling before HIV testing."6'
2. Voluntary Testing with Informed Consent (Non-Specific)
The second category of statutes requires informed consent but does
not insist on written consent. For example, Indiana's statute provides:
[A] person may not perform a screening or confirmatory test for the
antibody or antigen to the human immunodeficiency virus (HIV) without
the consent of the individual to be tested or a representative. . . . A
physician ordering the test or the physician's authorized representative
shall document whether or not the individual has consented. 2
Sixteen states follow this pattern,63  with eleven requiring pretest
counseling. 64
3. General Medical Consent
While the majority of states require informed consent specifically for
HIV testing, several states do not require such specific consent. In
particular, Texas5 and Kentucky66 permit HIV testing based on general
consent to medical treatment.
In Texas, the relevant statute provides that "[a] person who has signed
a general consent form for the performance of medical tests or procedures
'o ME. REV. STAT. ANN. tit 5, § 19204-A (West 2002).
6I MAss. REGS. CODE tit. 130, § 405.402 (2002).
62 IND. CODE § 16-41-6-1 (2002).
6 The sixteen states are Colorado, Connecticut, Delaware, Florida, Indiana, Louisiana,
Missouri, Montana, New Hampshire, New Mexico, North Carolina, Ohio, Oregon, Virginia,
Washington, and West Virginia.
m The eleven states are Connecticut, Delaware, Florida, Louisiana, Missouri, Montana, New
Mexico, Ohio, Virginia, Washington, and West Virginia.
TEX. HEALTH & SAFETYCODE ANN. §§ 81.105, 81.106 (Vernon 2002).
KY. REv. STAT. ANN. § 214.181(2)-(3) (Banks-Baldwin 2002).
6'7 In addition to these two states, Arkansas, Georgia, Illinois, and Mississippi allow testing
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is not required to also sign or be presented with a specific intent form
relating to medical tests or procedures to determine HIV infection. 68 In
addition, the statute allows oral consent if there is evidence that the HIV
test has been explained to the individual and consent was obtained. 69
Kentucky's law also affords substantial opportunity for HIV testing
without informed consent. In particular, testing without informed consent
is permissible (1) when an individual "has signed a general consent form
for the performance of general medical procedures and tests" or (2) "[i]n
any emergency situation where informed consent of the patient cannot
reasonably be obtained before providing health-care services."' The
Kentucky General Assembly clearly wanted to encourage widespread
testing, as evidenced in the statute's description of the legislative intent.
7 1
In fact, under Kentucky's scheme, it is difficult to imagine a clinical setting
in which HIV testing of patients without their consent would be
prohibited.
4. Exceptions to General Informed Consent Requirements
Even states that generally require consent for HIV testing may have
exceptions that permit testing without consent under specific
circumstances. For example, New York normally requires written informed
consent, but a party "is to submit to a physical, mental or blood
examination by a designated physician after the commencement of an
action in which the mental or physical condition . . . of a party is in
controversy, upon notice by the other party."72 The Supreme Court of New
York has held that, where a party voluntarily informs the opposing party of
his or her HIV or AIDS status, an HIV test may be administered without
the informing party's consent.73  Meanwhile, Missouri allows the
Department of Health and Senior Services to obtain a court order to test
certain individuals after reasonable efforts have been made to obtain
informed consent if "there are reasonable grounds to believe that an
individual is infected with HIV and there is clear and convincing evidence
of a serious and present threat to others posed by the individual if
TEX. HEALTH & SAFETYCODE ANN. § 81.106 (Vernon 2002).
69 Id. § 81.105.
70 KY. REV. STAT. ANN. § 214.181(2)-(3) (Banks-Baldwin 2002).
Cf KY. REV. STAT. ANN. § .214.635 (Banks-Baldwin 2002) (requiring the state to estimate
the potential impact of HIV infection on state expenditures).
12 People v. Durham, 553 N.Y.S.2d 944, 947 (N.Y. Sup. Ct. 1990) (emphasis added by the
court) (citing N.Y. C.P.L.R. 3121 (McKinney 2002)).
73 553 N.Y.S.2d at 947.
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infected. 74 Likewise, Georgia allows testing to protect the public only after
obtaining the subject's consent or upon successful petition for a court
order.75 A court must find "clear and convincing evidence that the person
is reasonably likely to be infected with HIV and that there is a compelling
need to protect the public health."76 Such statutory language establishes a
relatively high threshold both for evidence that an individual is infected,
and for evidence that the individual poses a threat to the community.
Moreover, in Missouri and Georgia, court adjudication of these issues
provides due process protections.
While Georgia, Missouri, and New York thus permit HIV testing
without consent in relatively limited circumstances, at least three other
states, Arkansas, Illinois, and Mississippi, carve out potentially broad
exceptions to consent.
Arkansas permits HIV testing without full informed consent when (1)
a physician determines that the testing is necessary for appropriate
diagnosis and treatment of a patient, and the patient has provided general
consent to the physician for medical treatment;77 or (2) a health care
provider risks becoming infected with HIV after he or she has come in
direct contact with the blood or bodily fluids of an individual. 7 The second
exception affords only a modicum of discretion as long as "exposure" is
clearly defined. However, the first exception could cover virtually any
situation where a physician thinks a patient is infected and the patient has
sought any kind of medical care. Similarly, Mississippi allows testing
without consent "if the hospital or physician determines that the test is
necessary for diagnostic purposes to provide appropriate care or treatment
to the person to be tested, or ... to protect the health and safety of other
patients or persons providing care and treatment to the person to be
tested."79 Such unfettered discretion could lead to abuse by individual
physicians or by institutions. To reduce the likelihood of abuse, states
", Mo. ANN. STAT. § 191.674(1) (West 2002).
7' GA. CODEANN. § 31-17A-2 (2002).
76 GA. CODE ANN. § 31-17A-3 (2002).
7 ARx. CODE ANN. § 20-15-905(c) (1) (Michie 2002) ("Informed consent, information, and
counseling are not required for the performance of an HIV test when, in the judgment of
the physician, such testing is medically indicated to provide an appropriate diagnosis and
treatment to the subject of the test provided that the subject of the test has otherwise
provided his or her consent to such physician for medical treatment.").
" ARK. CODE ANN. § 20-15-905(b) (1) (Michie 2002) ("Consent is not required for a health
care provider or health facility to perform a test when a health care provider or employee of
a health facility is involved in a direct skin or mucous membrane contact with the blood or
bodily fluids of an individual which is of a nature that may transmit HIV, as determined by a
physician in his medical judgment.").
" MISS. CODE ANN. § 41-41-16 (2000).
111:1 (2002)
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could either promulgate clear criteria for applying exceptions to informed
consent or require an impartial decision-maker to determine in each
instance whether an exception applies.
A different ambiguity-that of potential conflict between H1V testing
provisions-plagues Illinois law. While one statute demands written
consent,80 another allows HIV testing based only on general consent to treatment
if a physician determines testing is medically necessary.8 ' Specifically, the
latter statute states:
[W]ritten informed consent, information and counseling are not
required for the performance of an HIV test.., when in the judgment of
the physician, such testing is medically indicated to provide appropriate
diagnosis and treatment to the subject of the test, provided that the subject of
the test has otherwise provided his or her consent to such physician for
medical treatment.
8
Absent clear legislative intent to the contrary, such exceptions should be
narrowly interpreted in light of the general consensus favoring informed
consent and voluntary testing.
B. Prenatal HIV Testing Statutes
Of the fifty states and the District of Columbia, only seventeen have
83specific prenatal HIV testing statutes. In states without such statutes, the
general HIV testing laws apply, and most such states have policies and
programs addressing perinatal HIV transmission.8 4 These policies and
initiatives most commonly emphasize education, counseling, and providing
testing for all pregnant women.8 - The seventeen states that have prenatal
testing statutes generally feature two types of statutes: (1) routine offer of
and informed consent required for prenatal HIV testing; or (2) routine
prenatal HIV testing with an implicit or explicit "opt-out" provision.
1. Routine Offer of and Informed Consent Required for Prenatal HIV Testing
Eleven states routinely offer HIV counseling and testing to pregnant
women and make testing itself voluntary, based explicitly on informed
410 ILL. COMP. STAT. 305 / 4 (2002).
410 ILL. COMP. STAT. 305 / 8 (2002).
12 Id. (emphasis added).
83 See supra note 52.
Zita Lazzarini et al., Abstract, State Efforts To Reduce Perinatal HIV Transmission, 12 PRoc.
INT'L CONF. AIDS 4410 (1998).
85 Id.
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consent, pursuant to a specific prenatal testing provision.86 California's
statute exemplifies this scheme:
The prenatal care provider primarily responsible for providing prenatal
care to a pregnant patient shall offer human immunodeficiency virus
(HIV) information and counseling to every pregnant patient. The
prenatal care provider primarily responsible for providing prenatal care
to a pregnant patient shall offer an HIV test . . . to every pregnant
patient. . . . If the pregnant woman voluntarily consents to testing, the
provider shall arrange for HIV testing directly or by referral . .87
The only significant difference between such specific statutory regimes and
those predicated on general HIV testing statutes requiring informed
consent is that the former specifically require physicians to offer all
pregnant women HIV testing one or more times during pregnancy.
2. Routine Prenatal HIV Testing with an Explicit or Implicit Opt-Out Provision
Six states routinely conduct prenatal HIV testing pursuant to a specific
statute. 88 Routine testing means that the HIV test is incorporated into the
battery of tests that pregnant women normally receive. Usually, women are
informed of the general nature of the battery of tests, but the tests will be
performed unless the woman actively objects or refuses ("opts out").
Florida's statute exemplifies this opt-out scheme:
The prevailing professional standard of care in this state requires each
health care provider and midwife who attends a pregnant woman to
counsel the woman to be tested for human immunodeficiency virus....
If a pregnant woman objects to HIV testing, reasonable steps shall be
taken to obtain a written statement of such objection. 9
Ideally, under an opt-out system, pregnant women would receive
sufficient information about individual tests to provide them with notice of
testing and a meaningful opportunity to accept or refuse. One concern of
patient advocates, however, is that routine testing may mean that a patient
will not receive any real notice or that she will not realize she can refuse or
delay the HIV test.90 The language in some prenatal HIV testing statutes
86 These states are California, Connecticut (which has both voluntary and routine testing
provisions), Delaware, Indiana, Iowa, Maryland, New Jersey, Tennessee, Virginia,
Washington, and West Virginia.
CAL. HEALTH & SAFETY CODE § 125107(b)-(d) (West 2002).
s These states are Arkansas, Florida, Illinois, Michigan, Rhode Island, and Texas.
89 FLA. STAT. ANN. § 384.31(2) (West 2002).
80 Ruth R. Faden et al., Warrants for Screening Programs: Public Health, Legal, and Ethical
111:1 (2002)
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bears out this concern. For example, Michigan's statute provides:
A physician or an individual otherwise authorized by law to provide
medical treatment to a pregnant woman shall take or cause to be taken,
at the time of the woman's initial examination, test specimens of the
woman. . . [for] HIV or an antibody to HIV. . . . This subsection does
not apply if, in the professional opinion of the physician or other person,
the tests are medically inadvisable or the woman does not consent to be
tested.91
Although the language clearly indicates that testing, while routine, should
be voluntary (based on consent), the law could also permit routine testing
without real notice or right to opt out. This statute does not include a clear
mechanism for notification, counseling, or refusal.
At least one state, Connecticut, requires routine offer and testing with
informed consent during pregnancy, as well as routine testing with an opt-
out provision at delivery. Specifically, a physician providing prenatal care is
required to inform the patient that HIV testing is "routine" and offer her
HIV testing at two different times during pregnancy (usually in the first
and third trimesters).92 On these occasions, the patient can opt in by giving
her informed consent to be tested. At delivery, however, a woman who has
no evidence of prior testing in her records, or no records at all, will be
tested routinely unless she objects in writing. 9
Routine HIV testing is motivated by the desire to provide all pregnant
women with counseling and testing. Yet, existing laws may needlessly de-
emphasize consent, since their goal could arguably be achieved by
mandating counseling and offering voluntary testing (with informed
consent) at multiple stages of pregnancy. By subjecting pregnant women to
Frameworks, in WOMEN AND THE NEXT GENERATION: TOwARDS MORALLY ACCEPTABLE PUBLIC
POLICY FOR HIV TESTING OF PREGNANT WOMEN AND NEWBORNS 3 (Ruth R. Faden et al. eds.,
1991).
" MICH. COMP. LAws ANN. § 333.5123 (West 2002).
92 CONN. GEN. STAT. ANN. § 19a-593(a) (West 2002) ("Each health care provider giving
prenatal care to pregnant women in this state shall inform her, or ascertain from the
woman's medical record that such information has already been provided to her, that HIV
testing is a part of routine prenatal care and shall inform her of the health benefits to
herself and her newborn of being tested for HIV infection.").
" CONN. GEN. STAT. ANN. § 19a-593(b) '(West 2002) ("If, during the current pregnancy, an
HIV-related test has not been documented in the patient's medical record at admission for
delivery of the baby, then the health care provider responsible for the patient's care shall
inform the pregnant woman as required under subsection (a)'of this section and shall also
inform her of the -health benefits to herself and her newborn of being tested for HIV
infection either before delivery or within twenty-four hours after delivery and, in the
absence of specific written objection, shall cause such test to be administered.").
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different standards for H1V testing, the routine testing laws that are
currently in place undermine women's autonomy and decrease incentive
for health care professionals to educate pregnant women about HIV.
During pregnancy, women are more likely to accept HIV testing and modify
risky behaviors if they understand the potential benefits both to themselves
and their fetuses. Therefore, any provision that makes it less likely that
physicians will take time to educate pregnant women about the relevant
risks and benefits should be avoided.
In short, the most important element of any H1V testing law is whether
it affords a substantive right to choose supported by truly informed
consent. As illustrated by the routine testing laws, the notion that testing is
voluntary may be illusory when women are not told that they can refuse.
For example, unless the law requires that a pregnant woman be notified of
her right to refuse, either she or her physician may assume that she cannot
refuse, or that refusal could result in penalties for the patient or for the
physician. Under such circumstances, only careful scrutiny of the actual
practices of health care professionals can determine whether patients have
a realistic opportunity to make an informed choice about HIV testing.
C. Newborn HIV Testing Statutes
Of the fifty states and the District of Columbia, only four states have
94specific newborn HIV testing provisions.
Connecticut requires testing of all newborns for whom there is no
record of maternal testing during pregnancy or delivery. 5 The relevant
statute states that "[t] he administrative officer or other person in charge of
each institution caring for newborn infants shall cause to have
administered to every such infant in its care an HIV-related test . . . as
soon after birth as is medically appropriate."96 The provision is intended as
a final backstop for determining the need for intervention. Nonetheless, it
provides one exception-an infant will not be tested if the parents object
on religious grounds.97
Indiana permits but does not require physicians to test newborns
94 Because HIV antibody testing of newborns immediately after birth measures exposure to
HIV rather than actual infection, newborn testing reveals the mother's true infection status,
not the baby's. Thus, most infants who initially test "positive" for HIV antibodies will revert
to "negative" over time. Detecting exposure in a newborn is still useful, however, to
determine whether treatment with antiretrovirals to reduce the risk of infection is
appropriate.
5 CoNN. GEN. STAT. ANN. § 19a-55(a) (West 2002).
96 Id.
97
CoNN. GEN. STAT. ANN. § 19a-55 (b) (West 2002).
111:l1 (2002)
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without parental consent if the mother had not been tested and a
physician believes testing is medically necessary.98 If such testing occurs, the
mother must receive notification and counseling. 99 As in Connecticut,
parents may prevail on religious grounds, but they must submit such
objections in writing.' °°
Rhode Island generally requires informed consent'o but allows several
exceptions. One such exception is when "the person to be tested is under
one year of age. '0°
Finally, New York regulations illustrate the state's goal of universal
prenatal HIV counseling and testing:
[H]ospital maternity staff are to approach all women in labor who do not
have an HIV test result from prenatal care and offer them expedited HIV
testing with preliminary results available as soon as possible, but no later
than 48 hours .... For those women without prenatal HIV test results
who decline HIV testing during delivery, hospitals are required to
conduct expedited HIV testing of all newborns with preliminary results
available in the same time frame.
0 3
The state Department of Health explicitly warns that "[w] omen should be
aware that their newborn will be tested even if they choose not to be [sic]
and that it is better to be tested for HIV during pregnancy than to wait
until delivery.',
0 4
IV. CHALLENGES TO STATE HIV TESTING LAWS
State newborn testing provisions, exceptions to general informed
consent, and opt-out regimes reflect the federal trend toward routine HIV
testing at the cost of women's autonomy. Accordingly, much commentary
has been devoted to the constitutionality, public health justifications, and
ethical issues surrounding general, °5 prenatal,0 6 and newborn HIV
9' IND. CODE § 16-41-6-4(a) (2002).
'9 IND. CODE§ 16-41-6-4(b) (2002).
10 IND. CODE § 16-41-6-4(e) (2002).
... R.I. GEN. LAWS § 23-6-12 (2002).
11
2 R.I. GEN. LAWS§ 23-6-14(1) (2002).
103 N.Y. STATE DEP'T OF HEALTH, CHANGES IN THE STATE'S NEWBORN HIV SCREENING PROGRAM
(1999), available at http://www.health.state.ny.us/nysdoh/aids/pindex.htm.
104 Id.
105 See, e.g., Sean Anderson, Individual Privacy Interests and the "Special Needs" Analysis for
Involuntary Drug and HIV Tests, 86 CALIF. L. REv. 119 (1998); Scott Burnis, Law and the Social
Risk of Health Care: Lessons from HIV Testing, 61 ALB. L. REv. 831 (1998); Stacey B. Fishbein,
Pre-Conviction Mandatory HIV Testing: Rape, AIDS, and the Fourth Amendment, 28 HOFSTRA L.
REv. 835 (2000); Kathleen Fultz, Mandatory AIDS or HIV Testing, 21 J. Juv. L. 152 (2000);
19
Lazzarini and Rosales: Legal Issues Concerning Public Health Efforts To Reduce Perinatal HIV Transmission
Published by Yale Law School Legal Scholarship Repository, 2003
YALE JOURNAL OF HEALTH POLICY, LAW, AND ETHICS
testing. 107
A. Ethical Issues
While conflicts between the principles of autonomy and beneficence
in health care are now usually resolved in favor of patient autonomy,
concerns over fetal welfare complicate matters in the perinatal context.10 8
With perinatal HIV testing in particular, public health officials and
clinicians must weigh the burdens on a woman's autonomy against the
potential benefits of early diagnosis and treatment to both the woman and
her fetus. Earlier in the HIV / AIDS epidemic, neither mandatory nor
routine testing provided much benefit to pregnant women. However, since
1995, advances in antiretroviral treatment and success in reducing
perinatal transmission provided a strong public health justification for
Kellie E. Lagitch, Mandatory HIV Testing: An Orwellian Proposition, 72 ST. JOHN'S L. REV. 103
(1998); Brenda E. Perez, Competing Rights and Policies in Mandatory Testing for HIV: People v.
Doe, 24 AM.J. CRIM. L. 617 (1997);Justin P. Runke, Fourth Amendment Balancing Act: Special
Needs of Rape Victims Justify Court-Ordered H1V Testing of the Accused, 29 SETON HALL L. REv.
1094 (1999).
106 See, e.g., Elizabeth B. Cooper, Why Mandatory HIV Testing of Pregnant Women and Newborns
Must Fail: A Legal, Historical, and Public Policy Analysis, 3 CARDOZO WOMEN'S L.J. 13 (1996);
Dorian L. Eden, Is It Constitutional and Will It Be Effective? An Analysis of Mandatory HIV
Testing of Pregnant Women, 11 HEALTH MATRIX 659 (2001); Sheree Gootzeit, Expedited HIV
Testing: An Unnecessary Test That Is Allowing the State To Trample on a Woman's Constitutional
Rights, 7 CARDOZO WOMEN'S L.J. 187 (2001); Theresa M. McGovern, Mandatory HIV Testing
and Treating of Childbearing Women: An Unnatural, Illegal, and Unsound Approach, 28 COLUM.
HUM. RTS. L. REv. 469 (1997);JulietJ. McKenna, Where Ignorance Is Not Bliss: A Proposal for
Mandatory HIV Testing of Pregnant Women, 7 STAN. L. & POL'Y REv. 133 (1996); Evans
McMillion, The Case Against Mandatory HIV Testing of Pregnant Women: The Legal and Public
Policy Implications, 5 DUKEJ. GENDER L. & POL'Y 227 (1998); Jennifer Sinton, Rights Discourse
and Mandatory HIV Testing of Pregnant Women and Newborns, 6J. L. & POL'Y 187 (1997).
107 See, e.g., Kelly D. Bryce, Mandatory HIV Testing of Newborns: Is There a Better Way To Achieve
the State's Goal of Preventing Transmission of HIV to Newborns and Ensuring Them Treatment?, 4
QuINNiWIAc HEALTH L.J. 69 (2000); Michele M. Contreras, New York's Mandatory HIV Testing
of Newborns: A Positive Step Which Results in Negative Consequences for Women and Their Children,
20 WOMEN'S RTs. L. REP. 21 (1998); Colin Crawford, Changing Positions and Entrenched
Polemics: A Brief History of the Association to Benefit Children's Views on Pediatric HIV Testing,
Counseling, and Care, 24 FORDHAM URB. L.J. 729 (1997); Colin Crawford, An Argument for
Universal Pediatric HIV Testing, Counseling, and Treatment, 3 CARDOZO WOMEN'S L.J. 31 (1996);
Melinda Madison, Tragic Life or Tragic Death-Mandatory Testing of Newbornsfor H1V-Mothers'
Rights Versus Children's Health, 18 J. LEGAL MED. 361 (1997); Catherine H. McCabe, Ryan
White Care Amendments: Mandatory H1V Testing of Newborns and a Woman's Right to Privacy, 1
DEPAUL J. HEALTH CARE L. 373 (1996); Eileen M. McKenna, The Mandatory Testing of
Newborns for HIV. Too Much, Too Little, Too Late, 13 N.Y.L. SCH.J. HUM. RTS. 307 (1997).
'08 Frank A. Chervenak & Laurence B. McCullough, Common Ethical Dilemmas Encountered in
the Management of HIV-Infected Women and Newborns, 39 CLINICAL OBSTETRICS & GYNECOLOGY
411, 412 (1996); Paquita de Zulueta, The Ethics of Anonymized HIV Testing of Pregnant Women:
A Reappraisal, 26J. MED. ETHiCS 16, 18 (2000).
111:1 (2002)
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testing. Accordingly, the debate has shifted significantly in favor of
increased testing. 109
B. Legal Challenges to General Testing Laws
Despite the prevalence of general HIV testing statutes,110 these
provisions have sparked scant litigation. The most recent case, Sierakowski
v. Ryan,"' arose over the Illinois AIDS Confidentiality Act,"2 which affords
physicians discretion to test without patient consent. In Sierakowski,
although the plaintiff refused an HIV test during a routine hospital visit,
he was tested nonetheless and notified of the results at his next
appointment. Sierakowski alleged that the Illinois statute violated his rights
under the Fourth and Fourteenth Amendments. The District Court for the
Northern District of Illinois dismissed the suit,113 and the Seventh Circuit
affirmed."14 According to the circuit court, Sierakowski did not have Article
III standing because his test results were negative." 5 The court found that
not only were his alleged injuries abstract and conjectural, but also
"[t]here [was] nothing in the proposed amended complaint or the record
below to suggest that future injury [was] likely and that Sierakowski face [d]
... Some commentators have argued that various anonymous HIV testing programs,
including the Survey of Child-Bearing Women (SCBW), unethically withhold information
from pregnant women, similar to the withholding of information from subjects in the
infamous Tuskegee study of syphilis. See Ronald Bayer, Rethinking the Testing of Babies and
Pregnant Women for HIV Infection, 7 J. CLINICAL ETHICS 77 (1996); William Raspberry, Shades
of Tuskegee, WASH. POST, Sept. 22, 1997, at A19. This claim turns the principle of autonomy
on its head by arguing that it is the withholding of information obtained from non-
consensual testing that offends or violates a pregnant woman's autonomy. Cf Amy L.
Fairchild & Ronald Bayer, Uses and Abuses of Tuskegee, 284 SCIENCE 919 (1999) (highlighting
the withholding of treatment, not information); Gershon B. Grunfeld, Dissimilarities Between
Tuskegee Study and HIV / AIDS Programs Emphasized, 82 AM. J. PUB. HEALTH 1176 (1992)
(same). The SCBW was a "screening project in which all newborns were screened for H1V...
to try to get some idea of what HlV infection prevalence was among their mothers and from
there to generalize on HIV infection in the United States." Linda Valleroy, Address at the
70th Meeting of the Blood Products Advisory Committee, Department of Health and
Human Services, Food and Drug Administration (Dec. 14, 2001) (transcript available at
http://www.fda.gov/ohrms/dockets/ac/O1/transcripts/3817t2.htm). The survey found a
0.2- to 0.3-percent prevalence of HIV in the general population of the United States. Id.
Those asserting that withholding information from pregnant women is unethical
successfully lobbied to end Public Health Service support for the SCBW.
... Currently, there are thirty-seven states with general HIV testing statutes on the books. See
supra Part III.
Il 223 F.3d 440 (7th Cir. 2000).
1 410 ILL. COMP. STAT. 305 / 8 (2002).
Sierakowski v. Ryan, No. 98-C7088, 1999 U.S. Dist. LEXIS 6573 (N.D. Ill. Apr. 26, 1999).
223 F.3d at 441.
"5 Id. at 443.
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an immediate threat of harm."" 6 By deciding the case on the narrowest
possible grounds (applying the findings only to Sierakowski), the court
overlooked the possibility that other patients could be harmed and
provided no guidance to other health care providers and patients on when
non-consensual testing is permitted."
7
Sierakowski remains the only case that directly challenged the
legitimacy of a general HIV testing statute. Other cases arose over statutory
application. In Doe v. High Tech Institute, Inc.,l .. for example, although the
Colorado statute allows testing without consent under certain
circumstances, the plaintiff's situation did not fall within statutory
exceptions. The plaintiff was told that his blood sample was obtained only
for rubella testing. There was no other demonstrable reason for taking the
plaintiffs blood, and there was no legitimate reason for testing the sample
for HIV. The court held that "a person has a privacy interest in his or her
blood sample and in the medical information that may be obtained from
it," and that "an additional, unauthorized test.., can be sufficient to state
a claim for relief for intrusion upon seclusion." 9 In other words, it is
illegal to obtain a blood sample for non-HIV testing purposes and then
subject the sample to HIV testing without medical justification.
In suits challenging the propriety of an HIV test conducted without
consent, state courts often stress the defendant's intent. For example, in
Doe v. Ohio State University Hospital &Clinics, the court ruled that a plaintiff
must demonstrate that the defendant "knew" he or she did not have the
patient's consent.120 Mere knowledge that consent is legally required does
not establish that, on the occasion when the defendant performed the test
in dispute, the defendant knew he or she was violating the statute.1
116 Id.
"' Future plaintiffs challenging the Illinois provision might consider an alternative
argument. Rather than seeking injunctive relief, which would prohibit future incidents,
they might seek damages for the non-consensual testing to which they have already been
subjected by claiming that the testing violated their rights under the Fourth and Fourteenth
Amendments. An action for damages rather than injunctive relief would avoid the problem
of standing presented in Sierakowski because a plaintiff in a case for damages would only
have to show that an injury had occurred, not that the injury was likely to occur again. The
threat of a viable legal action would help prevent physicians from overstepping their
bounds, thus reducing invasions of privacy like that in Sierakowski.
1i8 972 P.2d 1060 (Colo. Ct. App. 1998).
'19 Id. at 1068. "Intrusion upon seclusion" is a variant of invasion of privacy.
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C. Legal Challenges to Perinatal Testing Laws
As of 2002, thirty-seven states require prenatal syphilis testing. 2 2 Other
states mandate testing for disorders such as hepatitis B, phenylketonuria
(PKU), and sickle cell disorder. 23 Research in both state and federal
databases yields a paucity of cases challenging statutes requiring prenatal
or newborn testing for diseases such as PKU and syphilis, 24 and
commentators have noted the absence of legal challenges to other
prenatal testing programs. 25 Based on the lack of litigation over perinatal
screening in general, it is not surprising that perinatal HIV testing statutes
have not been widely challenged.
Moreover, where perinatal testing laws have spawned legal protest,
plaintiffs generally have not prevailed. In one such case, the Connecticut
Hospital Association filed a complaint against Connecticut Governor John
Rowland, seeking pre-enforcement injunctive relief from the state's
newborn HIV testing statute. 26 The Association claimed that the provision,
which requires the screening of newborns whose mothers refused testing
or for whom test results were not available, violates the Fourth and
Fourteenth Amendment rights of pregnant women and newborns. The
district court denied immediate injunctive relief, and hospitals soon
became accustomed to the changes. Hence, the Connecticut Hospital
122 Three other states (Louisiana, Maine, and Missouri) require the patient's consent for
testing. New Hampshire repealed its statutory mandate in 1986. Minnesota requires that
midwives recommend testing. The remaining eight states (Florida, Iowa, Michigan,
Mississippi, North Carolina, Oregon, Virginia, and Wisconsin) have no testing requirement.
12 Eden, supra note 106, at 669.
12' Research was conducted using Westlaw. Searches were performed both in the federal
cases database and in the all-states database. A separate search was conducted in both
databases for sickle cell testing. This yielded only eighteen cases, none of which involved
legal challenges specifically aimed at sickle cell testing. Rather, the cases dealt with medical
malpractice in diagnosis or treatment.
"5 See, e.g., R. Curtis McNeil, Prenatal HJV Testing Under Ohio Revised Code Section 3701.242:
The Doctors' [sic] Dilemma and the State's Shame, 22 DAYrON L. REv. 301, 309 (1997) ("No
recorded cases have challenged the ability of the State of Ohio to require gonorrhea
testing .... Although prenatal syphilis testing has been the law throughout the United
States for over 50 years, research has not uncovered a single reported case, in any state or
federal jurisdiction, where the authority of the state to require these tests has even been
questioned."). The only successful challenges to non-HIV, mandatory prenatal testing
programs appear to have come against testing for sickle cell disease. These challenges were
accompanied by growing public awareness that sickle cell screening clearly discriminated
against African-Americans. The public outcry, more than individual litigation, led to a
change in federal law that required voluntary testing aimed at preventing, diagnosing, and
treating the disease while maintaining confidentiality. Kristin M. Raffone, The Human
Genome Project: Genetic Screening and the Fundamental Right of Privacy, 26 HOFSTRA L. REv. 503,
521 (1997).
16 Conn. Hosp. Ass'n v. Rowland, No. 3:99CV1923 (D. Conn. Oct. 16, 2000).
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Association ultimately did not pursue its challenge, and the case ended
with a stipulation of dismissal on July 19, 2001.
Some commentators perceive the lack of legal challenges to prenatal
and newborn testing in general as evidence of tacit moral acceptance of
these practices. According to one observer, "[w]hen a woman seeks
prenatal treatment, she is consenting to be tested for what is mandated by
the state in which she is seeking treatment. She submits to testing and
treatment.' 27 This characterization of prenatal testing casts the decision to
seek prenatal care as a privilege. From this perspective, the prospect of
testing is no more objectionable than the drug test that a prospective
employee implicitly consents to when she applies for a job. Yet, this
characterization overlooks the coercive nature of attaching conditions to a
decision to seek prenatal care. A pregnant woman is virtually bound to
seek medical care at some stage of pregnancy unless she is willing to risk
her own life and that of her fetus by giving birth without the assistance of
medically trained personnel. Thus, pregnant women are faced with a
starkly limited range of alternatives: they can avail themselves of medical
assistance, which may involve unwanted testing, or receive no care at all.
For public health and policy reasons, it seems unsound to so constrain
women's choices. This unfortunate outcome can be avoided by giving
women a real choice as to prenatal testing.
D. Beyond Testing Statutes
Even if all, or nearly all, pregnant women accept HIV testing,
reduction of perinatal HIV transmission requires additional steps. At
present, the best medical advice for an HIV-infected woman is that she
receive antiretroviral treatment according to current guidelines (usually
combination therapy), adhere to the medication schedule through




Based on existing data, it may also be advisable for some women to deliver
via caesarean section. 12 9 Such measures come into play after testing and are,
currently, fully voluntary. Nevertheless, as evidence mounts on the efficacy
of these interventions in reducing mother-to-child transmission, pressure
to comply with these treatments and procedures will increase. Therefore, it
is relevant to consider whether, and under what circumstances, a woman's
127 Eden, supra note 106, at 670.
128 See generally CDC Recommendations, supra note 13.
' The American College of Obstetrics and Gynecology, supra note 41, recommends that
"HIV-positive pregnant women with high viral loads ... be counseled by physicians about
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physician can force her to undergo medical interventions for the benefit of
her fetus rather than herself. While there does not appear to be any cases
in which health officials or prosecutors sought to force a pregnant woman
with HIV to accept treatment, the issue of forced intervention in a
pregnancy has arisen in other contexts that bear reviewing.
1. Court-Ordered Ceasarian Deliveries
During the past several decades, courts have issued a series of opinions
concerning physicians who sought court orders to perform caesarean
sections on women who, for religious or other reasons, refused the surgery.
The seminal case is that of Angela C. in 1990.130 Angela C. was diagnosed
with a recurrence of cancer late in her pregnancy and faced death before
her due date. Before falling into a coma, she refused the request of one of
her doctors to perform a caesarean section to try and save her premature
fetus. The District of Columbia Court of Appeals concluded that the lower
court had erred in granting the order for surgery over the mother's
objections, upholding the right of a mother to refuse interventions that
pose a risk to her merely for the benefit of her fetus.
131
The case of Angela C. provides strong support for a pregnant woman's
right to make choices about medical treatment during pregnancy, even
when those decisions are contrary to medical advice and may have serious
consequences for herself or her fetus. According to Angela C., a pregnant
woman with HIV should retain the right to accept or refuse antiretroviral
therapy or a caesarean section regardless of the potential benefit to the
fetus because both pose some risk to her.
130 In re A.C., 573 A.2d 1235 (D.C. 1990).
131 Id. at 1243. Neither Angela nor her baby survived despite the surgery.
12 State courts have followed the holding in Angela C. even when the fetus is much closer to
full term (and thus clearly "viable"). For example, in In re Baby Boy Doe, 632 N.E.2d 326 (Ill.
App. Ct. 1994), the court found that a mother may refuse a caesarean section immediately
before delivery even though physicians predicted serious harm to the infant without
intervention. However, the case of Angela C. did not fully resolve the issue of maternal
surgery, as local and state courts have both granted and denied orders requested by
physicians. See Robin M. Trindel, Fetal Interests v. Maternal Rights: Is the State Going Too Far?,
24 AKRON L. REv. 743 (1991). Compare Pemberton v. Tallahassee Mem. Reg'l Med. Ctr., 66
F. Supp. 2d 1247 (N.D. Fla. 1999) (holding that forced caesarean section performed in the
interests of an unborn baby does not violate the mother's constitutional rights), and
Jefferson v. Griffin Spalding County Hosp. Auth., 274 S.E.2d 457 (Ga. 1981) (upholding a
forced caesarean order), with In re Baby Boy Doe, 632 N.E.2d 326, 333 (Ill. App. Ct. 1994)
(finding that a forced caesarean section, undertaken for the benefit for the fetus, cannot
pass constitutional muster).
25
Lazzarini and Rosales: Legal Issues Concerning Public Health Efforts To Reduce Perinatal HIV Transmission
Published by Yale Law School Legal Scholarship Repository, 2003
YALE JOURNAL OF HEALTH POLICY, LAW, AND ETHICS
2. Court-Ordered Medical Care
Other recent cases, however, suggest possible limitations on women's
autonomy during pregnancy. In 2000, a Massachusetts prosecutor obtained
an order to confine a pregnant woman until delivery where the woman
and her husband refused to seek any prenatal care or medical assistance
for birth, and where an earlier child was believed to have died from lack of
medical care. 133 After birth, the healthy child was placed in state custody.
The parents were detained on contempt charges for refusing to provide
information on the fate of a third child, who the couple maintained died
as a result of a miscarriage. 34
Although this case has not been appealed or published, and thus
provides little legal precedent, it illustrates a prosecutor's discretion to
characterize a pregnant woman's choices as dangerous to her fetus. An
aggressive prosecutor in this or another jurisdiction could attempt to
intercede in the pregnancy of an HIV-positive woman to force either
treatment with antiretrovirals or other interventions at delivery.
3. Drug Use During Pregnancy
A separate series of cases involves criminal charges against women for
actions during pregnancy that could harm their fetuses. In many cases,
prosecutors jailed women and removed their children from custody for
"delivery" of drugs to the fetus during pregnancy or birth.135 Appellate
courts have largely upheld these decisions. In addition, some states
automatically seek custody of children suffering from withdrawal symptoms
due to maternal drug use during pregnancy.136
In 2001, the U.S. Supreme Court decided Ferguson v. City of
Charleston,137 which involved a South Carolina hospital's practice of testing
... See Paul E. Parker, Thrust into the Spotlight-Judge Takes the High Road, PROVIDENCEJ.-BuLL.,
Feb. 4, 2002, at BO1; David Wedge, Judge Confines Cult Mom to Secure Hospital, Judge's Ruling
Locks Up Defiant Pregnant Cult Mom, BOSTON HERALD, Sept. 1, 2000, at 001; Editorial, Woman
Imprisoned over Prenatal Care, L.A. TIMES, Sept. 12, 2000, at B8.
"' Paul E. Parker, Judge Jails Sect Couple for Defying Court's Order, PROVIDENCEJ.-BULL, Feb. 6,
2002, at A01; Denise Lavoie, Mass. Seeks Alleged Sect Baby, AP ONLINE, Jan. 30, 2002, available
at 2002 WL 11685641 AP.
"' CTR. FOR REPROD. L. & POL'Y, PUNISHING WOMEN FOR THEIR BEHAVIOR DURING PREGNANCY:
AN APPROACH THAT UNDERMINES WOMEN'S HEALTH AND CHILDREN'S INTERESTS, at
http://www.crlp.org/pub-artpunwom.html (Sept. 11, 2000).
"' Practice Commentaries, N.Y. Fain. Ct. § 1012 (2002). Thus, for almost two decades, it has
been well-settled law in some states that "[a] newborn baby having withdrawal symptoms is
prima facie a neglected baby." In re Vanessa F., 351 N.Y.S.2d 337, 340 (Surr. Ct. N.Y. 1974);
cf In re "Male" R., 422 N.Y.S.2d 819 (N.Y. Fam. Ct. 1979).
"' 532 U.S. 67 (2001).
111:1 (2002)
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pregnant women for drugs and providing the results directly to law
enforcement officials for prosecution purposes. The Court held that such a
practice violated a woman's constitutional rights under the Fourth
Amendment. The Court ruled that if health officials intend to collect
information for criminal prosecution, they must ensure that women are
aware of their constitutional rights.' Thus, Ferguson suggests that some
prenatal testing regimes may violate the Fourth Amendment prohibition
against unreasonable search and seizure. However, the case also
acknowledges public health claims related to prenatal testing. Therefore, if
a prenatal HIV testing statute does not set criminal penalties and includes
provision of notice to women that testing would be performed, a court
following Ferguson might uphold the law regardless of consent.
4. Child Protection Provisions
HIV-related cases that have invoked state child welfare or protection
powers have mainly been concerned with medical care of a child after
birth. For example, in an Oregon child custody case, an HIV-infected
woman refused ZDV treatment for her newborn and wanted to breastfeed
against medical advice. 139 A family court intervened and granted legal
custody of the child to the state. The mother and father retained physical
custody on the following conditions: they were not to breastfeed the child,
and they had to submit to monitoring by social services to ensure
compliance with the order.
Another case involved a woman in Maine who did not want to give her
HIV-infected toddler antiretrovirals.140 The woman had already suffered
through the illness and death of another child from AIDS and "expressed
her distrust of the drug therapy and declined to permit her son to
participate (in experimental treatment studies) at that time.' 14' Health
officials sought an order that would require the woman to give ZDV to her
child or else grant the state custody of her child. 42 The court denied the
request, reasoning that a woman who had already cared for and lost one
RId. at 85.
... PAUL PHILPOT, THE GROUP FOR THE REAPPRAISAL OF AIDS, TYSON FAMILY LOSES IN OREGON
COURT; EUGENE JUDGE DENIES HIV-POsrrIvE MOM RIGHT To BREAST FEED, ASSIGNS CUSTODY
OF INFANT TO STATE (1999), available at
http://www.rethinkingaids.com/Archive/1999/RA9906TysonsLose.html.
"o In re Nikolas E., 720 A.2d 562 (Me. 1998) (holding that a mother's decision to delay
experimental drug therapy did not constitute serious parental neglect that would warrant a
child protection order). But see A.D.H. v. Dep't of Human Res., 640 So.2d 969, 970 (Ala.
Civ. App. 1994).
"' Id. at 563.
142 Id.
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child to AIDS could weigh the potential side effects and benefits of
treatment and determine what was best for her child.
Both the Oregon and Maine courts struggled to determine what would
be best for the child in question. The key difference may have been that
the Oregon child was uninfected, and all the testimony in the case
suggested that avoiding breastfeeding could prevent infection. The child
in Maine, on the other had, was infected and already quite ill. Thus, it
seems the Oregon court ruled against parental autonomy because
intervention could protect a healthy child from a deadly infection, while
the Maine court preserved parental decision-making where child
medications are difficult to take, have significant side effects, and will not
effect a cure.
Indeed, the Oregon and Maine cases address the medical care of a
child after birth, not choices that women make during pregnancy. Parental
decisions regarding children's care are governed by a set of rules and case
law that differs significantly from those governing the decisions of
pregnant women. For instance, child protection authorities have much
greater latitude to act in "the best interests of the child" after birth. 43
Nonetheless, child welfare cases may be relevant to the issue of perinatal
testing and treatment because they illustrate the powerful pressures that
can come into play when public health authorities believe a parent is
endangering a child (or future child).
5. Criminal Exposure and Transmission Laws
Some commentators worry that women who refuse testing, treatment,
or interventions at delivery could be prosecuted under state laws that
specifically criminalize knowing exposure to, or transmission of, HIV, or
even under criminal laws such as assault, attempted murder, or reckless
endangerment.'" In fact, of the twenty-four states that have HIV-specific
laws criminalizing exposure or transmission, 145 only Oklahoma's law
143 E.g., CONN. GEN. STAT. § 17a-103b(a) (2002).
114 Nan D. Hunter, Complications of Gender: Women and HIV Disease, in AIDS AGENDA:
EMERGING ISSUES IN CIVIL RIGHTS, 5, 27-30 (Nan D. Hunter & William B. Rubenstein eds.,
1992); Andre A. Panossian et al., Criminalization of Perinatal HIV Transmission, 19J. LEGAL
MED. 223 (1998); Christina M. Shriver, State Approaches to Criminalizing the Exposure of HIV
Problems in Statutory Construction, Constitutionality, and Implications, 21 N. ILL. U. L. REv. 319
(2001); Heather Sprintz, The Criminalization of Perinatal AIDS Transmission, 3 HEALTH
MATRIX 495 (1993); RicHARD ELLIOT, CAN. HIV / AIDS LEGAL NETWORK & CAN. AIDS Soc'Y,
CRIMINAL LAW & HIV / AIDS: FINAL REPORT (1997), available at
http://www.aidslaw.ca/Maincontent/issues/criminallaw/finalreports/CRFR-COVER.html.
"5 Zita Lazzarini et al., Evaluating the Impact of Criminal Laws on HIV Risk Behavior, 30 J. L.
MED. ETHIcs 239 (2002).
11.1:1 (2002)
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currently exempts in utero exposure. 4 However, a query of all fifty state
health departments on the possible use of criminal provisions against
pregnant women revealed that no department had knowledge of any
attempts or intentions on the part of health officials to use criminal law in
this manner.147 Officials in only one state, Washington, had specifically
examined their criminal HIV transmission law for applicability to
pregnancy and concluded that the statute would only apply if, a woman
intended to infect her infant.
4
Given the apparent lack of interest in prosecuting perinatal H1V
transmission, it seems unlikely that a woman who complies with public
health recommendations for HIV testing and treatment during pregnancy
would be charged with knowing exposure or transmission, even if her child
became infected. A more likely scenario for possible criminal charges
would involve women who refuse treatment, do not comply with treatment
regimens, insist on breastfeeding, or avoid prenatal care altogether. Such
choices would clearly run against the weight of public health and clinical
recommendations.
In sum, based on the lessons of Angela C. and related cases, a pregnant
woman with HIV who refuses her physician's advice to have a caesarean
delivery or take antiretrovirals would not likely be compelled to undergo
surgery or accept treatment. Nonetheless, prosecutors might pursue
criminal charges in spite of health department policies to the contrary. It
remains unclear, moreover, whether health officials or physicians might
use the threat of criminal prosecution or child custody actions to coerce
women into accepting antiretroviral treatment or other medical
interventions during pregnancy or birth.
V. RECOMMENDATIONS FOR REDUCING PERINATAL HIV TRANSMISSION
In its report, Reducing the Odds: Preventing Perinatal Transmission of HIV
in the United States, the IOM recommended universal testing with patient
notification as a routine component of prenatal care.149 The IOM stated
that implementing such a policy would require numerous other steps,
46 OKLA. STAT. tit. 21 § 1192.1 (2002) ("It shall be unlawful for any person knowing that he
or she has Acquired Immune Deficiency Syndrome (AIDS) or is a carrier of the human
immunodeficiency virus (HIV) and with intent to infect another, to engage in conduct
reasonably likely to result in the transfer of the person's own blood, bodily fluids containing
visible blood, semen, or vaginal secretions into the bloodstream of another, or through the
skin or other membranes of another person except during in utero transmission of blood or bodily
fluids.") (emphasis added).
14 Lazzarini et al., supra note 84.
Id. at 4410.
INST. OF MED., supra note 30, at 6.
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including (1) educating prenatal care providers; (2) improving provider
practices and bringing the clinical practice guidelines of professional
organizations in line with enumerated best practices; (3) contractually
imposing success in universal testing as a performance measure; (4)
improving coordination of care and access to high-quality HIV treatment
so that all women who are tested can take advantage of the most successful
intervention strategies currently available; and (5) addressing underlying
reasons that drive some HIV-infected women to refuse testing or
treatment.
The IOM also noted that substantial federal and state funds are
needed for a coordinated effort to meet these specific objectives and to
achieve the overarching goal of reducing perinatal HIV transmission.
Specifically, the IOM noted that certain groups of women are most likely to
"fall through the cracks" of the current counseling, testing, and treatment
systems and urged the government to take extra steps to reach these
women. Such women include those in correctional settings, women
without access to prenatal care, and women who do not intend to become
pregnant. In addition, the IOM urged efforts that would reduce primary
infection in women since such efforts can contribute markedly to reducing
perinatal HIV transmission.
Overall, the IOM recommendations address a broad range of issues
and would improve prenatal care for all women as well as reduce HIV
infection. Unfortunately, much of the attention at the state level has
focused on laws related to testing and on the manner of testing (e.g.,
voluntary, mandatory, or routine). Some legislators appear to have
followed the IOM's assumption that the consent process must be changed
or eliminated to increase levels of testing among pregnant women. Yet
there is little empirical evidence to support that this is the only way, or the
best way, to increase testing rates and reduce HIV transmission.
A comprehensive perinatal HIV transmission policy ought to include
mechanisms directed at changing the behavior of health care
professionals, such as (1) training health care workers to provide effective
HIV education and counseling to pregnant patients, (2) incorporating
education, counseling, and testing of pregnant women as performance
measures;150 and 3) reimbursing physicians, nurses, and midwives who
spend time educating and counseling pregnant women. A comprehensive
program should also address the needs of pregnant women more directly.
Public education campaigns in many states have already raised awareness
of the benefits of HIV testing during pregnancy without reducing women's
' See Zita Lazzarini & Deborah Elman, Legal Options for Achieving Public Health Outcomes, 8J.
PUB. HEALTH MGMT. & PRAc. 65 (2002).
111: 1 (2002)
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control over their bodies. In addition, as the IOM noted, it is critical to
reach women least likely to receive prenatal care, encouraging them to
seek care as early in pregnancy as possible and to make health-promoting
changes while pregnant.
Finally, where states have moved to routine testing, officials need to
examine how routine testing is actually implemented to ensure that
"routine" does not amount to "compulsory." While, in theory, routine
testing with the option to opt-out confers a greater degree of autonomy
than mandatory testing, in practice, this may not be the case. Adoption of
the rhetoric of "routine" testing may subject women to testing with little or
no meaningful information about the test or their right to refuse and still
receive medical care. Under such circumstances, not only do women lose
the opportunity to make an autonomous choice about medical care, but
also-and more importantly-health care providers lose the opportunity
to educate them, either because women opt not to receive any care at all,
or because the testing process involves no real dialogue about HIV testing
and treatment.
Indeed, given the problems that may arise from routine testing with an
opportunity to opt out, an opt-in method may be more effective and
prudent. In other words, a pregnant woman should have to give her
express permission for an HIV test to be performed. Once provided with
the necessary counseling, the majority of pregnant women might choose to
opt in, thus furthering the goal of testing all pregnant women. 151 At the
same time, the express-permission requirement would assure that some
discussion of the test takes place and promote use of the opportunity to
educate.
VI. CONCLUSION
Although most states (1) emphasize the importance of informed
consent for HIV testing, both prenatally and generally, and (2) recognize
the privacy and constitutional interests accompanying a person's medical
information, many jurisdictions allow HIV testing without full informed
consent in certain circumstances. With general testing provisions, common
exceptions to informed consent include protecting health care providers
and the public, as well as enhancing the ability of health care providers to
diagnose and treat patients effectively. The majority of the seventeen states
that have statutes specifically addressing prenatal testing also require
informed consent for testing. However, since the IOM issued its report in
' See CDC Revised Guidelines, supra note 37, at 68.
31
Lazzarini and Rosales: Legal Issues Concerning Public Health Efforts To Reduce Perinatal HIV Transmission
Published by Yale Law School Legal Scholarship Repository, 2003
YALE JOURNAL OF HEALTH POLICY, LAW, AND ETHICS
1999,152 some have modified their laws to require "routine" testing at some
point in pregnancy, and two states have instituted mandatory newborn
testing programs. Similarly, professional organizations have developed a
substantial consensus on the value of routine (universal), voluntary HIV
testing during pregnancy, though they differ subtly on the meaning of
routine testing, the role of informed consent, and the extent of health care
providers' duties to educate pregnant women on the risks of HIV as part of
the testing process. The push to achieve routine testing risks eliminating
any real opportunity both to educate women and to provide women with a
real choice to accept or refuse testing. Focus on legal reform may also
obscure another important issue-whether HIV-infected women can be
persuaded to accept treatment, and if so, whether they can be persuaded
to adhere to prenatal and postnatal medication regimens.
Yet, the efficacy of prenatal treatments in preventing HLV transmission
provides a strong public health justification for ensuring that all women
know their HIV status and have the opportunity to receive antiretroviral
therapy, for themselves and for their children. Widespread adoption of
prenatal counseling and testing and acceptance of treatment by HIV-
infected women have already significantly reduced the annual incidence of
HIV transmission to newborns. With one hundred or fewer cases per year
since 2000, the U.S. has achieved remarkable success. Nevertheless, some
preventable transmission continues to occur. Thus, the challenge of how
best to reduce or eliminate new cases without sacrificing important values
and compromising women's role in their own health care remains. An
effective way to balance a woman's autonomy with the welfare of her fetus
would be to adopt comprehensive H1V prevention measures that focus on
changing the behavior of health care providers, educating pregnant
women, making testing "routine" in the sense that the test is available to all
women at every stage of pregnancy, ensuring that all pregnant women
know they should be tested, and providing adequate prenatal care for all
women before changing or eliminating the requirement of informed
consent. Such a strategy would provide women a real choice to delay or
refuse testing and treatment while still educating them about HIV.
152 See INST. OF MED., supra note 30.
111: 1 (2002)
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